Needle Free Drug Delivery Devices Market Size & Competitors

Needle free drug delivery devices market is segmented into needle free injection systems and microneedle devices. The needle-free drug injection system market is expected to reach USD 606 million in the current year and is anticipated to grow at a CAGR of 4% to 2035. Whereas the microneedle devices market is expected to reach USD 2.11 billion in the current year, growing at a CAGR of 6.2% during the forecast period.

Over the years, the incidence rates of chronic diseases, such as diabetes, autoimmune diseases, cardiovascular diseases, and oncological diseases have surged, accounting for major cases of death and disability across the world. In fact, according to the Center for Managing Chronic Disease at the University of Michigan, over 50% of the global population is affected by some form of chronic disease. These conditions pose escalating challenges among patients in terms of cost, mobility and mortality. To address the aforementioned challenges, pharmaceutical companies are adopting various innovative and patient focused strategies.

Currently, oral and parenteral routes are employed for administering prescribed medications to manage such chronic conditions. While oral route of administration is convenient and patient friendly, parenteral administration of drugs is most prevalent approach due to several advantages, including rapid onset of action, precise dosing control and higher bioavailability. However, it is worth noting that choice of administration route, factors such as properties of drug, condition of patient, desired speed and reliability of therapeutic effects influence the choice of administration route. Despite these advantages offered by the conventional (parenteral) drug delivery approaches, there are various challenges that can hinder medication adherence and ultimately affect the desired therapeutic outcomes. These challenges, particularly with intramuscular and subcutaneous routes include pain during administration, risk of cross contamination, needlestick injuries, and inaccurate dosing.

In response, technological advancement in drug delivery has led to the development of safer alternatives like safety syringes and retractable needle syringes, needle free systems, jet injectors, pen injectors and microneedle patches. These advanced systems enable safer administration of drugs owing to their improved design, functionality and usability in comparison to conventional needles. This has led towards a discernible shift in patient preferences towards painless drug administration, driving the increasing acceptance and adoption of these systems. Owing to the increasing adoption of needle free drug delivery devices, the market for global needle free drug delivery devices is expected to experience substantial growth during the forecast period.

Research Coverage:

The report on needle free drug delivery devices market covers the following elements:

A preface providing an introduction to the full report, Needle Free Drug Delivery Devices Market to 2035.
A summary of the systematic research methodology used for the study, including research assumptions, forecast models, and a blend of primary and secondary research techniques, alongside the analytical frameworks utilized in the report.
A description of forecasting methodologies and analytical frameworks used to access market trends, focusing on the key factors affecting market dynamics. It also emphasizes the stringent quality control processes adopted to ensure accuracy and transparency of the data presented.
A detailed review of the economic factors impacting the needle free drug delivery devices market, such as fluctuations in currency, foreign exchange rates, and trade barriers. It also examines the effect of global historical economic shifts, including recession and inflation to predict future market trends.
An executive summary of the insights captured during our research, offering an insightful overview of the current needle free drug delivery devices market landscape. It also highlights the projected evolution of the market in the short, medium, and long term.
An overview of needle free injection systems and microneedles, highlighting the growing demand for devices that enable painless administration of medication in the home healthcare settings. It emphasizes the need for such devices, specifically in terms of the rising incidence and prevalence of chronic diseases. Additionally, the section discusses various types of needle free injectors and microneedles, along with their specifications and varied mechanisms of action. It also features a brief discussion on the challenges related to the R&D efforts associated with such healthcare devices and insights on anticipated future trends.

Needlefree Drug Delivery 2

An in-depth analysis of the overall market landscape of needle free drug delivery providers, based on several relevant parameters, including year of establishment, company size (on the basis of employee count), location of their headquarter, actuation mechanism, route of administration, type of formulation administered, type of drug delivered, therapeutic area, and device usability.
An in-depth analysis of the overall market landscape of microneedle device providers, based on several relevant parameters, such as year of establishment, company size (on the basis of employee count), location of their headquarter, stage of development, type of microneedle, type of formulation administered, route of administration, therapeutic area and type of drug delivered.

Needlefree Drug Delivery 3

A competitiveness analysis of needle-free injection systems, based on the supplier power and product specifications. The analysis allows the stakeholder companies to compare their existing capabilities within and beyond their respective peer groups and identify opportunities to achieve a competitive edge in the industry.
A competitiveness analysis of the microneedle devices, based on the supplier power and product specifications. The analysis enables the product providers to compare their existing capabilities within and beyond their respective peer groups and identify opportunities to achieve a competitive edge in the industry.
A comprehensive likely drug candidate analysis, featuring list of marketed drugs/ therapies and pipeline candidates that are expected to be developed in combination with needle free injectors in the near future. The analysis is based on a variety of relevant parameters, including current status of development, dose concentration, dosing frequency, route of administration, type of dose, expected patent expiry (relevant only for marketed drugs) and information on product sales (relevant only for marketed drugs).
A comprehensive likely drug candidate analysis, featuring list of marketed drugs / therapies and pipeline candidates that are anticipated to be developed in combination with microneedles in the near future. The analysis is based on a variety of relevant parameters, including current status of development, dose concentration, dosing frequency, route of administration, type of dose, expected patent expiry (relevant only for marketed drugs) and information on product sales (relevant only for marketed drugs).
Detailed profiles of key players in needle free drug delivery devices market headquartered in North America, Europe, Asia-Pacific and Rest of the World. Each profile provides a brief overview of the company along with information on its product portfolio, and an insightful recent development and future outlook.
A qualitative assessment of the various megatrends ongoing in the needle free drug delivery devices market, such as technological advancements in design, functionality, usability and features, along with expanded applications of needle free systems and increasing focus on personalized medicine.
An in-depth analysis of factors that can impact the growth of needle free drug delivery devices market. The section features various key drivers, potential restraints, emerging opportunities, and existing challenges.
A comprehensive evaluation of the current market size and future market growth potential of the needle-free injection system market (first product category within the needle free drug delivery devices market)over the next 11 years. On the basis of multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the market size, till 2035.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across different product types, including fillable devices and prefilled devices.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across different actuation mechanisms, including spring-powered devices, compressed-gas devices and other devices.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across product usability, including reusable devices and disposable devices.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across type of load, including liquid-based devices, powder-based devices and projectile / depot-based devices.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across different routes of administration, including subcutaneous, intramuscular and intradermal.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across application area, including insulin delivery, pain management, vaccination and dermatology.
Detailed forecast estimates of the current and future opportunity within the needle-free injection system market across key geographical regions including North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.
Detailed projections of the current microneedle market size (second product category within the needle free drug delivery devices market), along with the future market growth potential over the next 11 years. On the basis of several relevant parameters including likely adoption trends and through primary validations, we have provided an informed estimate on the market size till 2035.
Detailed estimation of the current and future opportunity within the microneedle device market (second product category within the needle free drug delivery devices market)across different type of microneedle, such as hollow microneedles, solid microneedles, dissolving microneedles and coated microneedles.
Detailed estimation of the current and future opportunity within the microneedle device market across different types of material used, such as polymer microneedles, silicon microneedles, metal microneedles and ceramic microneedles.
Detailed estimation of the current and future opportunity within the microneedle device market across different application areas, such as insulin delivery, vaccination, pain management and oncology.
Detailed estimation of the current and future opportunity within the microneedle device market across different type of intervention, such as vaccines, therapeutic agents and other interventions.
Detailed estimation of the current and future opportunity within the microneedle device market across key geographical regions including North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.

Key Benefits of Buying this Report

The report provides valuable insights to market leaders and newcomers related to revenue estimations of the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, thereby improving their business positioning and developing more effective go-to-market strategies.
The report provides stakeholders with an overall outlook of the needle free drug delivery devices market, furnishing them with extensive information on significant factors that impact market such as market drivers, barriers, opportunities, and challenges.

1. PREFACE

1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases

3. MARKET DYNAMICS

3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

5. EXECUTIVE SUMMARY

6. INTRODUCTION

6.1. Chapter Overview
6.2. Historical Evolution of Drug Delivery Devices
6.3. Conventional Parenteral Delivery
6.3.1. Needlestick Injuries
6.3.1.1. Incidence Rate and Cost Burden of Needlestick Injuries
6.4. Minimally Invasive Drug Delivery
6.4.1. Factors Influencing Growth of Minimally Invasive Drug Delivery Systems
6.4.1.1. Rising Burden of Chronic Diseases
6.4.1.2. Healthcare Cost Savings
6.4.1.3. Need for Immediate Treatment in Emergency Situations
6.4.1.4. Growing Injectable Drugs Market
6.4.1.5. Need for Improving Medication Adherence
6.5. Needle-free Injection Technology
6.5.1. Key Components of Needle-free Injection Systems
6.5.1.1. Injection Device
6.5.1.2. Nozzle
6.5.1.3. Pressure Source
6.6. Operating Mechanism of Needle-free Injection Systems
6.7. Classification based on Type of Load
6.7.1. Powder-based Injectors
6.7.2. Liquid-based Injectors
6.7.3. Depot or Projectile Injectors
6.8. Classification based on Actuation Mechanism
6.8.1. Spring Loaded Jet Injectors
6.8.2. Battery Powered Jet Injectors
6.8.3. Gas Powered Jet Injectors
6.8.4. Laser Powered Injectors
6.8.5. Lorentz Force-based Injectors
6.9. Microneedle Devices
6.9.1. Types of Microneedle Devices
6.9.2. Advantages of Microneedle Devices
6.9.3. Operating Mechanism of Microneedle Devices
6.10. Key Challenges related to Needle-free Injection Systems and Microneedle Devices
6.11. Recent Advancements
6.12. Future Perspectives

7. MARKET LANDSCAPE: NEEDLE-FREE INJECTION SYSTEMS

7.1 Chapter Overview
7.2. Needle-free Injection System Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Company Size and Location of Headquarters
7.3. Needle-free Injection Systems: Overall Market Landscape
7.3.1. Analysis by Actuation Mechanism
7.3.2. Analysis by Route of Administration
7.3.3. Analysis by Type of Formulation Administered
7.3.4. Analysis by Type of Drug Delivered
7.3.5. Analysis by Therapeutic Area
7.3.6. Analysis by Usability
7.3.7. Analysis by Type of Formulation Administered and Actuation Mechanism

8. MARKET LANDSCAPE: MICRONEEDLE DEVICES

8.1 Chapter Overview
8.2. Microneedle Device Providers: Overall Market Landscape
8.2.1. Analysis by Year of Establishment
8.2.2. Analysis by Company Size
8.2.3. Analysis by Location of Headquarters
8.2.4. Analysis by Company Size and Location of Headquarters
8.3. Microneedle Devices: Overall Market Landscape
8.3.1. Analysis by Stage of Development
8.3.2. Analysis by Type of Microneedle
8.3.3. Analysis by Type of Formulation Administered
8.3.4. Analysis by Route of Administration
8.3.5. Analysis by Therapeutic Area
8.3.6. Analysis by Type of Drug Delivered
8.3.7. Analysis by Type of Microneedle and Type of Formulation Administered

9. PRODUCT COMPETITIVENESS ANALYSIS: NEEDLE-FREE INJECTION SYSTEMS

9.1 Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Product Competitiveness Analysis: Needle-free Injection Systems
9.4.1. Spring-based Needle-free Injection Systems
9.4.2. Gas-powered Needle-free Injection Systems
9.4.3. Other Needle-free Injection Systems

10. PRODUCT COMPETITIVENESS ANALYSIS: MICRONEEDLE DEVICES

10.1 Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.4. Product Competitiveness Analysis: Microneedle Devices
10.4.1. Dissolving Microneedle Devices
10.4.2. Hollow Microneedle Devices
10.4.3. Solid Microneedle Devices
10.4.4. Other Microneedle Devices

11. LIKELY DRUG CANDIDATES: NEEDLE-FREE INJECTION SYSTEMS

11.1 Chapter Overview
11.2. Marketed Drugs Candidates
11.2.1. Most Likely Candidates for Delivery via Needle-Free Injection Systems
11.2.2. Likely Candidates for Delivery via Needle-Free Injection Systems
11.2.3. Less Likely Candidates for Delivery via Needle-Free Injection Systems
11.2.4. Least Likely Candidates for Delivery via Needle-Free Injection Systems
11.3. Clinical Drug Candidates (Biologics)
11.3.1. Most Likely Candidates for Delivery via Needle-Free Injection Systems
11.3.2. Likely Candidates for Delivery via Needle-Free Injection Systems
11.3.3. Less Likely Candidates for Delivery via Needle-Free Injection Systems
11.3.4. Least Likely Candidates for Delivery via Needle-Free Injection Systems

12. COMPANY PROFILES: NEEDLE-FREE DRUG DELIVERY DEVICE PROVIDERS BASED IN NORTH AMERICA

12.1. Chapter Overview
12.2. Leading Needle-free Drug Delivery Device Providers in North America

12.2.1. Antares Pharma (Acquired by Halozyme)
12.2.1.1. Company Overview
12.2.1.2. Product Portfolio
12.2.1.3. Recent Development and Future Outlook
12.2.2. D’Antonio Consultants International
12.2.3. HNS International
12.2.4. INOVIO Pharmaceuticals
12.2.5. Medical International Technology
12.2.6. PharmaJet
12.2.7. Zogenix (acquired by UCB)
12.3. Other Leading Needle-free Drug Delivery Device Providers in North America
12.3.1. 3M
12.3.1.1. Company Overview
12.3.1.2. Product Portfolio
12.3.2. TheraJect

13. COMPANY PROFILES: NEEDLE-FREE DRUG DELIVERY DEVICE PROVIDERS BASED IN EUROPE

13.1. Chapter Overview
13.2. Leading Needle-free Drug Delivery Device Providers in Europe

13.2.1. INJEX Pharma
13.2.1.1. Company Overview
13.2.1.2. Product Portfolio
13.2.1.3. Recent Development and Future Outlook
13.3. Other Leading Needle-free Drug Delivery Device Providers in North America
13.3.1. Debiotech
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.2. Micropoint Technologies
13.3.3. Nemaura Pharma

14. COMPANY PROFILES: NEEDLE-FREE DRUG DELIVERY DEVICE PROVIDERS BASED IN ASIA-PACIFIC AND REST OF THE WORLD

14.1. Chapter Overview
14.2. Leading Needle-free Drug Delivery Device Providers in Asia-Pacific and Rest of the World

14.2.1. MIKA MEDICAL
14.2.1.1. Company Overview
14.2.1.2. Product Portfolio
14.2.1.3. Recent Development and Future Outlook
14.2.2. QS Medical Technology (Quinovare)
14.3. Other Leading Needle-free Drug Delivery Device Providers in North America
14.3.1. INCYTO
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.2. NanoPass Technologies

15. MEGATRENDS ANALYSIS

15.1. Chapter Overview
15.2. Key Megatrends
15.2.1. Technological Innovations
15.2.2. Applications in Personalized Medicine
15.2.3. Telemedicine Integration
15.2.4. Promising Potential in Driving Sustainability
15.2.5. Robust Regulatory Framework
15.2.6. Increase in Clinical Trial Activity

16. MARKET IMPACT ANALYSIS

16.1. Chapter Overview
16.2. Market Drivers
16.3. Market Restraints
16.4. Market Opportunities
16.5. Market Challenges
16.6. Conclusion

17. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET

17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Global Needle-free Injection Systems Market, till 2035
17.3.1. Scenario Analysis
17.3.1.1. Conservative Scenario
17.3.1.2. Optimistic Scenario
17.4. Key Market Segmentations

18. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT TYPE

18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Needle-free Injection Systems Market: Distribution by Product Type
18.3.1. Needle-free Injection Systems Market for Fillable Devices, till 2035
18.3.2. Needle-free Injection Systems Market for Prefilled Devices, till 2035
18.4. Data Triangulation and Validation

19. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY ACTUATION MECHANISM

19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Needle-free Injection Systems Market: Distribution by Actuation Mechanism
19.3.1. Needle-free Injection Systems Market for Spring-powered Devices, till 2035
19.3.2. Needle-free Injection Systems Market for Compressed-gas Devices, till 2035
19.3.3. Needle-free Injection Systems Market for Other Devices, till 2035
19.4. Data Triangulation and Validation

20. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT USABILITY

20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Needle-free Injection Systems Market: Distribution by Product Usability
20.3.1. Needle-free Injection Systems Market for Reusable Devices, till 2035
20.3.2. Needle-free Injection Systems Market for Disposable Devices, till 2035
20.4. Data Triangulation and Validation

21. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE OF LOAD

21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Needle-free Injection Systems Market: Distribution by Type of Load
21.3.1. Needle-free Injection Systems Market for Liquid-based Devices, till 2035
21.3.2. Needle-free Injection Systems Market for Powder-based Devices, till 2035
21.3.3. Needle-free Injection Systems Market for Projectile / Depot-based Devices, till 2035
21.4. Data Triangulation and Validation

22. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY ROUTE OF ADMINISTRATION

22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Needle-free Injection Systems Market: Distribution by Route of Administration
22.3.1. Needle-free Injection Systems Market for Subcutaneous Route, till 2035
22.3.2. Needle-free Injection Systems Market for Intramuscular Route, till 2035
22.3.3. Needle-free Injection Systems Market for Intradermal Route, till 2035
22.4. Data Triangulation and Validation

23. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION AREA

23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Needle-free Injection Systems Market: Distribution by Application Area
23.3.1. Needle-free Injection Systems Market for Insulin Delivery, till 2035
23.3.2. Needle-free Injection Systems Market for Pain Management, till 2035
23.3.3. Needle-free Injection Systems Market for Dermatology, till 2035
23.3.4. Needle-free Injection Systems Market for Vaccination, till 2035
23.4. Data Triangulation and Validation

24. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY GEOGRAPHY

24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Needle-free Injection Systems Market: Distribution by Geography
24.3.1. Needle-free Injection Systems Market in North America, till 2035
24.3.1.1. Needle-free Injection Systems Market in the US, till 2035
24.3.1.2. Needle-free Injection Systems Market in Canada, till 2035
24.3.2. Needle-free Injection Systems Market in Europe, till 2035
24.3.2.1. Needle-free Injection Systems Market in Germany, till 2035
24.3.2.2. Needle-free Injection Systems Market in the UK, till 2035
24.3.2.3. Needle-free Injection Systems Market in France, till 2035
24.3.2.4. Needle-free Injection Systems Market in Italy, till 2035
24.3.2.5. Needle-free Injection Systems Market in Spain, till 2035
24.3.3. Needle-free Injection Systems Market in Asia-Pacific, till 2035
24.3.3.1. Needle-free Injection Systems Market in China, till 2035
24.3.3.2. Needle-free Injection Systems Market in India, till 2035
24.3.3.3. Needle-free Injection Systems Market in Japan, till 2035
24.3.3.4. Needle-free Injection Systems Market in Australia, till 2035
24.3.4. Needle-free Injection Systems Market in Middle East and North Africa, till 2035
24.3.4.1. Needle-free Injection Systems Market in Egypt, till 2035
24.3.4.2. Needle-free Injection Systems Market in Saudi Arabia, till 2035
24.3.4.3. Needle-free Injection Systems Market in Israel, till 2035
24.3.5. Needle-free Injection Systems Market in Latin America, till 2035
24.3.5.1. Needle-free Injection Systems Market in Brazil, till 2035
24.3.5.2. Needle-free Injection Systems Market in Mexico, till 2035
24.3.5.3. Needle-free Injection Systems Market in Argentina, till 2035

25. GLOBAL MICRONEEDLE DEVICES MARKET

25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Global Microneedle Devices Market, till 2035
25.3.1. Scenario Analysis
25.3.1.1. Conservative Scenario
25.3.1.2. Optimistic Scenario
25.4. Key Market Segmentations

26. MICRONEEDLE DEVICES MARKET, BY TYPE OF MICRONEEDLE

26.1. Chapter Overview
26.2. Key Assumptions and Methodology
26.3. Microneedle Devices Market: Distribution by Type of Microneedle
26.3.1. Microneedle Devices Market for Hollow Microneedles, till 2035
26.3.2. Microneedle Devices Market for Solid Microneedles, till 2035
26.3.3. Microneedle Devices Market for Dissolving Microneedles, till 2035
26.3.4. Microneedle Devices Market for Coated Microneedles, till 2035
26.4. Data Triangulation and Validation

27. MICRONEEDLE DEVICES MARKET, BY TYPE OF MATERIAL USED

27.1. Chapter Overview
27.2. Key Assumptions and Methodology
27.3. Microneedle Devices Market: Distribution by Type of Material Used
27.3.1. Microneedle Devices Market for Polymer Microneedles, till 2035
27.3.2. Microneedle Devices Market for Silicon Microneedles, till 2035
27.3.3. Microneedle Devices Market for Metal Microneedles, till 2035
27.3.4. Microneedle Devices Market for Ceramic Microneedles, till 2035
27.4. Data Triangulation and Validation

28. MICRONEEDLE DEVICES MARKET, BY APPLICATION AREA

28.1. Chapter Overview
28.2. Key Assumptions and Methodology
28.3. Microneedle Devices Market: Distribution by Application Area
28.3.1. Microneedle Devices Market for Insulin Delivery, till 2035
28.3.2. Microneedle Devices Market for Pain Management, till 2035
28.3.3. Microneedle Devices Market for Vaccination, till 2035
28.3.4. Microneedle Devices Market for Oncology, till 2035
28.4. Data Triangulation and Validation

29. MICRONEEDLE DEVICES MARKET, BY TYPE OF INTERVENTION

29.1. Chapter Overview
29.2. Key Assumptions and Methodology
29.3. Microneedle Devices Market: Distribution by Type of Intervention
29.3.1. Microneedle Devices Market for Vaccines, till 2035
29.3.2. Microneedle Devices Market for Therapeutic Agents, till 2035
29.3.3. Microneedle Devices Market for Other Interventions, till 2035
29.4. Data Triangulation and Validation

30. MICRONEEDLE DEVICES MARKET, BY GEOGRAPHY

30.1. Chapter Overview
30.2. Key Assumptions and Methodology
30.3. Microneedle Devices Market: Distribution by Geography
30.3.1. Microneedle Devices Market in North America, till 2035
30.3.1.1. Microneedle Devices Market in the US, till 2035
30.3.1.2. Microneedle Devices Market in Canada, till 2035
30.3.2. Microneedle Devices Market in Europe, till 2035
30.3.2.1. Microneedle Devices Market in France, till 2035
30.3.2.2. Microneedle Devices Market in Spain, till 2035
30.3.2.3. Microneedle Devices Market in the UK, till 2035
30.3.2.4. Microneedle Devices Market in Germany, till 2035
30.3.2.5. Microneedle Devices Market in Italy, till 2035
30.3.3. Microneedle Devices Market in Asia-Pacific, till 2035
30.3.3.1. Microneedle Devices Market in China, till 2035
30.3.3.2. Microneedle Devices Market in Japan, till 2035
30.3.3.3. Microneedle Devices Market in India, till 2035
30.3.3.4. Microneedle Devices Market in Australia, till 2035
30.3.4. Microneedle Devices Market in Middle East and North Africa, till 2035
30.3.4.1. Microneedle Devices Market in Egypt, till 2035
30.3.4.2. Microneedle Devices Market in Saudi Arabia, till 2035
30.3.4.3. Microneedle Devices Market in Israel, till 2035
30.3.5. Microneedle Devices Market in Latin America, till 2035
30.3.5.1. Microneedle Devices Market in Brazil, till 2035
30.3.5.2. Microneedle Devices Market in Mexico, till 2035
30.3.5.3. Microneedle Devices Market in Argentina, till 2035

31. CONCLUDING REMARKS

32. EXECUTIVE INSIGHTS

32.1. Chapter Overview
32.2. Portal Instruments
32.2.1. Company Snapshot
32.2.2. Interview Transcript
32.3. Vaxess Technologies
32.3.1 Company Snapshot
32.3.2. Interview Transcript
32.4. Innoture
32.4.1. Company Snapshot
32.4.2. Interview Transcript

33. APPENDIX I: TABULATED DATA34. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

LIST OF FIGURES

Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Key Market Segmentation
Figure 3.3 Market Dynamics: Robust Quality Control
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Needle-free Injection Systems Market Landscape (I / II)
Figure 5.2 Executive Summary: Needle-free Injection Systems Market Landscape (II / II)
Figure 5.3 Executive Summary: Microneedle Devices Market Landscape (I / II)
Figure 5.4 Executive Summary: Microneedle Devices Market Landscape (II / II)
Figure 5.5 Executive Summary: Needle-free Injection Systems Market Sizing and Opportunity Analysis
Figure 5.6 Executive Summary: Microneedle Devices Market Sizing and Opportunity Analysis
Figure 6.1 Minimally Invasive Drug Delivery Systems: Driving Factors
Figure 6.2 Needle-free Jet Injectors: Key Components
Figure 6.3 Needle-free Jet Injection: Stages of Drug Delivery
Figure 6.4 Microneedle Devices: Drug Delivery Mechanism
Figure 7.1 Needle-free Injection System Providers: Distribution by Year of Establishment
Figure 7.2 Needle-free Injection System Providers: Distribution by Company Size
Figure 7.3 Needle-free Injection System Providers: Distribution by Location of Headquarters (Region)
Figure 7.4 Needle-free Injection System Providers: Distribution by Location of Headquarters (Country)
Figure 7.5 Needle-free Injection System Providers: Distribution by Company Size and Location of Headquarters (Region)
Figure 7.6 Needle-free Injection Systems: Distribution by Type of Actuation Mechanism
Figure 7.7 Needle-free Injection Systems: Distribution by Route of Administration
Figure 7.8 Needle-free Injection Systems: Distribution by Type of Formulation Administered
Figure 7.9 Needle-free Injection Systems: Distribution by Type of Drug Delivered
Figure 7.10 Needle-free Injection Systems: Distribution by Therapeutic Area
Figure 7.11 Needle-free Injection Systems: Distribution by Usability
Figure 7.12 Needle-free Injection Systems: Distribution by Type of Formulation Administered and Actuation Mechanism
Figure 8.1 Microneedle Device Providers: Distribution by Year of Establishment
Figure 8.2 Microneedle Device Providers: Distribution by Company Size
Figure 8.3 Microneedle Device Providers: Distribution by Location of Headquarters (Region)
Figure 8.4 Microneedle Device Providers: Distribution by Location of Headquarters (Country)
Figure 8.5 Microneedle Devices Providers: Distribution by Company Size and Location of Headquarters (Region)
Figure 8.6 Microneedle Devices: Distribution by Stage of Development
Figure 8.7 Microneedle Devices: Distribution by Type of Microneedle
Figure 8.8 Microneedle Devices: Distribution by Type of Formulation Administered
Figure 8.9 Microneedle Devices: Distribution by Route of Administration
Figure 8.10 Microneedle Devices: Distribution by Therapeutic Area
Figure 8.11 Microneedle Devices: Distribution by Type of Drug Delivered
Figure 8.12 Microneedle Devices: Distribution by Type of Microneedle and Formulation Administered
Figure 9.1 Product Competitiveness Analysis: Spring-based Needle-free Injection Systems
Figure 9.2 Product Competitiveness Analysis: Gas-powered Needle-free Injection Systems
Figure 9.3 Product Competitiveness Analysis: Other Needle-free Injection Systems
Figure 10.1 Product Competitiveness Analysis: Dissolving Microneedle Devices
Figure 10.2 Product Competitiveness Analysis: Hollow Microneedle Devices
Figure 10.3 Product Competitiveness Analysis: Solid Microneedle Devices
Figure 10.4 Product Competitiveness Analysis: Other Microneedle Devices
Figure 15.1 Megatrends in the Needle-free Drug Delivery Devices Market
Figure 17.1 Global Needle-free Injection Systems Market, till 2035 (USD Million)
Figure 17.2 Needle-free Injection Systems Market, till 2035: Conservative Scenario (USD Million)
Figure 17.3 Needle-free Injection Systems Market, till 2035: Optimistic Scenario (USD Million)
Figure 18.1 Needle-free Injection Systems Market: Distribution by Product Type
Figure 18.2 Needle-free Injection Systems Market for Fillable Devices, till 2035 (USD Million)
Figure 18.3 Needle-free Injection Systems Market for Prefilled Devices, till 2035 (USD Million)
Figure 19.1 Needle-free Injection Systems Market: Distribution by Actuation Mechanism
Figure 19.2 Needle-free Injection Systems Market for Spring-powered Devices, till 2035 (USD Million)
Figure 19.3 Needle-free Injection Systems Market for Compressed-gas Devices, till 2035 (USD Million)
Figure 19.4 Needle-free Injection Systems Market for Other Devices, till 2035 (USD Million)
Figure 20.1 Needle-free Injection Systems Market: Distribution by Product Usability
Figure 20.2 Needle-free Injection Systems Market for Reusable Devices, till 2035 (USD Million)
Figure 20.3 Needle-free Injection Systems Market for Disposable Devices, till 2035 (USD Million)
Figure 21.1 Needle-free Injection Systems Market: Distribution by Type of Load
Figure 21.2 Needle-free Injection Systems Market for Liquid-based Devices, till 2035 (USD Million)
Figure 21.3 Needle-free Injection Systems Market for Powder-based Devices, till 2035 (USD Million)
Figure 21.4 Needle-free Injection Systems Market for Projectile / Depot based Devices, till 2035 (USD Million)
Figure 22.1 Needle-free Injection Systems Market: Distribution by Route of Administration
Figure 22.2 Needle-free Injection Systems Market for Subcutaneous Route, till 2035 (USD Million)
Figure 22.3 Needle-free Injection Systems Market for Intramuscular Route, till 2035 (USD Million)
Figure 22.4 Needle-free Injection Systems Market for Intradermal Route, till 2035 (USD Million)
Figure 23.1 Needle-free Injection Systems Market: Distribution by Application Area
Figure 23.2 Needle-free Injection Systems Market for Insulin Delivery, till 2035 (USD Million)
Figure 23.3 Needle-free Injection Systems Market for Pain Management, till 2035 (USD Million)
Figure 23.4 Needle-free Injection Systems Market for Dermatology, till 2035 (USD Million)
Figure 23.5 Needle-free Injection Systems Market for Vaccination, till 2035 (USD Million)
Figure 24.1 Needle-free Injection Systems Market: Distribution by Geography
Figure 24.2 Needle-free Injection Systems Market in North America, till 2035 (USD Million)
Figure 24.3 Needle-free Injection Systems Market in the US, till 2035 (USD Million)
Figure 24.4 Needle-free Injection Systems Market in Canada, till 2035 (USD Million)
Figure 24.5 Needle-free Injection Systems Market in Europe, till 2035 (USD Million)
Figure 24.6 Needle-free Injection Systems Market in Germany, till 2035 (USD Million)
Figure 24.7 Needle-free Injection Systems Market in the UK, till 2035 (USD Million)
Figure 24.8 Needle-free Injection Systems Market in France, till 2035 (USD Million)
Figure 24.9 Needle-free Injection Systems Market in Italy, till 2035 (USD Million)
Figure 24.10 Needle-free Injection Systems Market in Spain, till 2035 (USD Million)
Figure 24.11 Needle-free Injection Systems Market in Asia-Pacific, till 2035 (USD Million)
Figure 24.12 Needle-free Injection Systems Market in China, till 2035 (USD Million)
Figure 24.13 Needle-free Injection Systems Market in India, till 2035 (USD Million)
Figure 24.14 Needle-free Injection Systems Market in Japan, till 2035 (USD Million)
Figure 24.15 Needle-free Injection Systems Market in Australia, till 2035 (USD Million)
Figure 24.16 Needle-free Injection Systems Market in Middle East and North Africa, till 2035 (USD Million)
Figure 24.17 Needle-free Injection Systems Market in Egypt, till 2035 (USD Million)
Figure 24.18 Needle-free Injection Systems Market in Saudi Arabia, till 2035 (USD Million)
Figure 24.19 Needle-free Injection Systems Market in Israel, till 2035 (USD Million)
Figure 24.20 Needle-free Injection Systems Market in Latin America, till 2035 (USD Million)
Figure 24.21 Needle-free Injection Systems Market in Brazil, till 2035 (USD Million)
Figure 24.22 Needle-free Injection Systems Market in Mexico, till 2035 (USD Million)
Figure 24.23 Needle-free Injection Systems Market in Argentina, till 2035 (USD Million)
Figure 25.1 Global Microneedle Devices Market, till 2035 (USD Million)
Figure 25.2 Microneedle Devices Market, till 2035: Conservative Scenario (USD Million)
Figure 25.3 Microneedle Devices Market, till 2035: Optimistic Scenario (USD Million)
Figure 26.1 Microneedle Devices Market: Distribution by Type of Microneedle
Figure 26.2 Microneedle Devices Market for Hollow Microneedles, till 2035 (USD Million)
Figure 26.3 Microneedle Devices Market for Solid Microneedles, till 2035 (USD Million)
Figure 26.4 Microneedle Devices Market for Dissolving Microneedles, till 2035 (USD Million)
Figure 26.5 Microneedle Devices Market for Coated Microneedles, till 2035 (USD Million)
Figure 27.1 Microneedle Devices Market: Distribution by Type of Material Used
Figure 27.2 Microneedle Devices Market for Polymer Microneedles, till 2035 (USD Million)
Figure 27.3 Microneedle Devices Market for Silicon Microneedles, till 2035 (USD Million)
Figure 27.4 Microneedle Devices Market for Metal Microneedles, till 2035 (USD Million)
Figure 27.5 Microneedle Devices Market for Ceramic Microneedles, till 2035 (USD Million)
Figure 28.1 Microneedle Devices Market: Distribution by Application Area
Figure 28.2 Microneedle Devices Market for Insulin Delivery, till 2035 (USD Million)
Figure 28.3 Microneedle Devices Market for Vaccination, till 2035 (USD Million)
Figure 28.4 Microneedle Devices Market for Pain Management, till 2035 (USD Million)
Figure 28.5 Microneedle Devices Market for Oncology, till 2035 (USD Million)
Figure 29.1 Microneedle Devices Market: Distribution by Type of Intervention
Figure 29.2 Microneedle Devices Market for Vaccines, till 2035 (USD Million)
Figure 29.3 Microneedle Devices Market for Therapeutic Agents, till 2035 (USD Million)
Figure 29.4 Microneedle Devices Market for Other Interventions, till 2035 (USD Million)
Figure 30.1 Microneedle Devices Market: Distribution by Geography
Figure 30.2 Microneedle Devices Market in North America, till 2035 (USD Million)
Figure 30.3 Microneedle Devices Market in the US, till 2035 (USD Million)
Figure 30.4 Microneedle Devices Market in Canada, till 2035 (USD Million)
Figure 30.5 Microneedle Devices Market in Europe, till 2035 (USD Million)
Figure 30.6 Microneedle Devices Market in Germany, till 2035 (USD Million)
Figure 30.7 Microneedle Devices Market in the UK, till 2035 (USD Million)
Figure 30.8 Microneedle Devices Market in France, till 2035 (USD Million)
Figure 30.9 Microneedle Devices Market in Italy, till 2035 (USD Million)
Figure 30.10 Microneedle Devices Market in Spain, till 2035 (USD Million)
Figure 30.11 Microneedle Devices Market in Asia-Pacific, till 2035 (USD Million)
Figure 30.12 Microneedle Devices Market in China, till 2035 (USD Million)
Figure 30.13 Microneedle Devices Market in India, till 2035 (USD Million)
Figure 30.14 Microneedle Devices Market in Japan, till 2035 (USD Million)
Figure 30.15 Microneedle Devices Market in Australia, till 2035 (USD Million)
Figure 30.16 Microneedle Devices Market in Middle East and North Africa, till 2035 (USD Million)
Figure 30.17 Microneedle Devices Market in Egypt, till 2035 (USD Million)
Figure 30.18 Microneedle Devices Market in Saudi Arabia, till 2035 (USD Million)
Figure 30.19 Microneedle Devices Market in Israel, till 2035 (USD Million)
Figure 30.20 Microneedle Devices Market in Latin America, till 2035 (USD Million)
Figure 30.21 Microneedle Devices Market in Brazil, till 2035 (USD Million)
Figure 30.22 Microneedle Devices Market in Argentina, till 2035 (USD Million)
Figure 30.23 Microneedle Devices Market in Mexico, till 2035 (USD Million)
Figure 31.1 Concluding Remarks: Needle-free Injection Systems: Market Landscape
Figure 31.2 Concluding Remarks: Microneedle Devices: Market Landscape
Figure 31.3 Concluding Remarks: Needle-free Injection Systems: Market Sizing and Opportunity Analysis
Figure 31.4 Concluding Remarks: Microneedle Devices: Market Sizing and Opportunity Analysis

LIST OF TABLES

Table 7.1 Needle-free Injection System Providers: Information on Year of Establishment, Company Size and Location of Headquarters (Region)
Table 7.2 List of Needle-free Injection Systems
Table 7.3 Needle-free Injection Systems: Information on Type of Actuation Mechanism
Table 7.4 Needle-free Injection Systems: Information on Route of Administration
Table 7.5 Needle-free Injection Systems: Information on Type of Formulation Administered
Table 7.6 Needle-free Injection Systems: Information on Type of Drug Delivered
Table 7.7 Needle-free Injection Systems: Information on Therapeutic Area
Table 7.8 Needle-free Injection Systems: Information on Usability
Table 8.1 Microneedle Device Providers: Information on Year of Establishment, Company Size and Location of Headquarters (Region)
Table 8.2 List of Microneedle Devices
Table 8.3 Microneedle Devices: Information on Stage of Development
Table 8.4 Microneedle Devices: Information on Type of Microneedle
Table 8.5 Microneedle Devices: Information on Type of Formulation Administered
Table 8.6 Microneedle Devices: Information on Route of Administration
Table 8.7 Microneedle Devices: Information on Therapeutic Area
Table 8.8 Microneedle Devices: Information on Type of Drug Delivered
Table 11.1 Marketed Molecules: Most Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.2 Marketed Molecules: Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.3 Marketed Molecules: Less Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.4 Marketed Molecules: Least Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.5 Clinical Drug Candidates (Biologics): Most Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.6 Clinical Drug Candidates (Biologics): Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.7 Clinical Drug Candidates (Biologics): Less Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.8 Clinical Drug Candidates (Biologics): Least Likely Candidates for Delivery via Needle-Free Injection Systems
Table 12.1 Antares Pharma: Company Snapshot
Table 12.2 Antares Pharma: Product Portfolio
Table 12.3 D’ Antonio Consultants International: Company Snapshot
Table 12.4 D’ Antonio Consultants International: Product Portfolio
Table 12.5 HNS International: Company Snapshot
Table 12.6 HNS International: Product Portfolio
Table 12.7 INOVIO Pharmaceuticals: Company Snapshot
Table 12.8 INOVIO Pharmaceuticals: Product Portfolio
Table 12.9 Medical International Technology: Company Snapshot
Table 12.10 Medical International Technology: Product Portfolio
Table 12.11 PharmaJet: Company Snapshot
Table 12.12 PharmaJet: Product Portfolio
Table 12.13 PharmaJet: Recent Developments and Future Outlook
Table 12.14 Zogenix: Company Snapshot
Table 12.15 Zogenix: Product Portfolio
Table 12.16 3M: Company Snapshot
Table 12.17 3M: Product Portfolio
Table 12.18 TheraJect: Company Snapshot
Table 12.19 TheraJect: Product Portfolio
Table 13.1 INJEX Pharma: Company Snapshot
Table 13.2 INJEX Pharma: Product Portfolio
Table 13.3 Debiotech: Company Snapshot
Table 13.4 Debiotech: Product Portfolio
Table 13.5 Micropoint Technologies: Company Snapshot
Table 13.6 Micropoint Technologies: Product Portfolio
Table 13.7 Nemaura Pharma: Company Snapshot
Table 13.8 Nemaura Pharma Product Portfolio
Table 14.1 Mika Medical: Company Snapshot
Table 14.2 Mika Medical: Product Portfolio
Table 14.3 QS Medical Technology (Quinovare): Company Snapshot
Table 14.4 QS Medical Technology (Quinovare): Product Portfolio
Table 14.5 QS Medical Technology (Quinovare): Recent Developments and Future Outlook
Table 14.6 INCYTO: Company Snapshot
Table 14.7 INCYTO: Product Portfolio
Table 14.8 NanoPass Technologies: Company Snapshot
Table 14.9 NanoPass Technologies: Product Portfolio
Table 32.1 Portal Instruments: Company Snapshot
Table 32.2 Vaxess Technologies: Company Snapshot
Table 32.3 Innoture: Company Snapshot
Table 33.1 Needle-free Injection System Providers: Distribution by Year of Establishment
Table 33.2 Needle-free Injection System Providers: Distribution by Company Size
Table 33.3 Needle-free Injection System Providers: Distribution by Location of Headquarters (Region)
Table 33.4 Needle-free Injection System Providers: Distribution by Location of Headquarters (Country)
Table 33.5 Needle-free Injection System Providers: Distribution by Company Size and Location of Headquarters (Region)
Table 33.6 Needle-free Injection Systems: Distribution by Type of Actuation Mechanism
Table 33.7 Needle-free Injection Systems: Distribution by Route of Administration
Table 33.8 Needle-free Injection Systems: Distribution by Type of Formulation Administered
Table 33.9 Needle-free Injection Systems: Distribution by Type of Drug Delivered
Table 33.10 Needle-free Injection Systems: Distribution by Therapeutic Area
Table 33.11 Needle-free Injection Systems: Distribution by Usability
Table 33.12 Needle-free Injection Systems: Distribution by Type of Formulation Administered and Actuation Mechanism
Table 33.13 Microneedle Device Providers: Distribution by Year of Establishment
Table 33.14 Microneedle Device Providers: Distribution by Company Size
Table 33.15 Microneedle Device Providers: Distribution by Location of Headquarters (Region)
Table 33.16 Microneedle Device Providers: Distribution by Location of Headquarters (Country)
Table 33.17 Microneedle Devices Providers: Distribution by Company Size and Location of Headquarters (Region)
Table 33.18 Microneedle Devices: Distribution by Stage of Development
Table 33.19 Microneedle Devices: Distribution by Type of Microneedle
Table 33.20 Microneedle Devices: Distribution by Type of Formulation Administered
Table 33.21 Microneedle Devices: Distribution by Route of Administration
Table 33.22 Microneedle Devices: Distribution by Therapeutic Area
Table 33.23 Microneedle Devices: Distribution by Type of Drug Delivered
Table 33.24 Microneedle Devices: Distribution by Type of Microneedle and Type of Formulation Administered
Table 33.25 Global Needle-free Injection Systems Market, till 2035: Base Scenario (USD Million)
Table 33.26 Needle-free Injection Systems Market, till 2035: Conservative Scenario (USD Million)
Table 33.27 Needle-free Injection Systems Market, till 2035: Optimistic Scenario (USD Million)
Table 33.28 Needle-free Injection Systems Market: Distribution by Product Type
Table 33.29 Needle-free Injection Systems Market for Fillable Devices, till 2035 (USD Million)
Table 33.30 Needle-free Injection Systems Market for Prefilled Devices, till 2035 (USD Million)
Table 33.31 Needle-free Injection Systems Market: Distribution by Actuation Mechanism
Table 33.32 Needle-free Injection Systems Market for Spring-powered Devices, till 2035 (USD Million)
Table 33.33 Needle-free Injection Systems Market for Compressed-gas Devices, till 2035 (USD Million)
Table 33.34 Needle-free Injection Systems Market for Other Devices, till 2035 (USD Million)
Table 33.35 Needle-free Injection Systems Market: Distribution by Product Usability
Table 33.36 Needle-free Injection Systems Market for Reusable Devices, till 2035 (USD Million)
Table 33.37 Needle-free Injection Systems Market for Disposable Devices, till 2035 (USD Million)
Table 33.38 Needle-free Injection Systems Market: Distribution by Type of Load
Table 33.39 Needle-free Injection Systems Market for Liquid-based Devices, till 2035 (USD Million)
Table 33.40 Needle-free Injection Systems Market for Powder-based Devices, till 2035 (USD Million)
Table 33.41 Needle-free Injection Systems Market for Projectile / depot based Devices, till 2035 (USD Million)
Table 33.42 Needle-free Injection Systems Market: Distribution by Route of Administration
Table 33.43 Needle-free Injection Systems Market for Subcutaneous Route of Administration, till 2035 (USD Million)
Table 33.44 Needle-free Injection Systems Market for Intramuscular Route of Administration, till 2035 (USD Million)
Table 33.45 Needle-free Injection Systems Market for Intradermal Route of Administration, till 2035 (USD Million)
Table 33.46 Needle-free Injection Systems Market: Distribution by Application Area
Table 33.47 Needle-free Injection Systems Market for Insulin Delivery, till 2035 (USD Million)
Table 33.48 Needle-free Injection Systems Market for Pain Management, till 2035 (USD Million)
Table 33.49 Needle-free Injection Systems Market for Dermatology, till 2035 (USD Million)
Table 33.50 Needle-free Injection Systems Market for Vaccination, till 2035 (USD Million)
Table 33.51 Needle-free Injection Systems Market: Distribution by Geography
Table 33.52 Needle-free Injection Systems Market in North America, till 2035 (USD Million)
Table 33.53 Needle-free Injection Systems Market in the US, till 2035 (USD Million)
Table 33.54 Needle-free Injection Systems Market in Canada, till 2035 (USD Million)
Table 33.55 Needle-free Injection Systems Market in Europe, till 2035 (USD Million)
Table 33.56 Needle-free Injection Systems Market in Germany, till 2035 (USD Million)
Table 33.57 Needle-free Injection Systems Market in the UK, till 2035 (USD Million)
Table 33.58 Needle-free Injection Systems Market in France, till 2035 (USD Million)
Table 33.59 Needle-free Injection Systems Market in Italy, till 2035 (USD Million)
Table 33.60 Needle-free Injection Systems Market in Spain, till 2035 (USD Million)
Table 33.61 Needle-free Injection Systems Market in Asia-Pacific, till 2035 (USD Million)
Table 33.62 Needle-free Injection Systems Market in China, till 2035 (USD Million)
Table 33.63 Needle-free Injection Systems Market in India, till 2035 (USD Million)
Table 33.64 Needle-free Injection Systems Market in Japan, till 2035 (USD Million)
Table 33.65 Needle-free Injection Systems Market in Australia, till 2035 (USD Million)
Table 33.66 Needle-free Injection Systems Market in Middle East and North Africa, till 2035 (USD Million)
Table 33.67 Needle-free Injection Systems Market in Egypt, till 2035 (USD Million)
Table 33.68 Needle-free Injection Systems Market in Saudi Arabia, till 2035 (USD Million)
Table 33.69 Needle-free Injection Systems Market in Israel, till 2035 (USD Million)
Table 33.70 Needle-free Injection Systems Market in Latin America, till 2035 (USD Million)
Table 33.71 Needle-free Injection Systems Market in Brazil, till 2035 (USD Million)
Table 33.72 Needle-free Injection Systems Market in Mexico, till 2035 (USD Million)
Table 33.73 Needle-free Injection Systems Market in Argentina, till 2035 (USD Million)
Table 33.74 Global Microneedles Devices Market, till 2035: (USD Million)
Table 33.75 Microneedles Devices Market, till 2035: Conservative Scenario (USD Million)
Table 33.76 Microneedles Devices Market, till 2035: Optimistic Scenario (USD Million)
Table 33.77 Microneedles Devices Market: Distribution by Type of Microneedle Devices
Table 33.78 Microneedles Devices Market for Hollow Microneedles, till 2035 (USD Million)
Table 33.79 Microneedles Devices Market for Solid Microneedles, till 2035 (USD Million)
Table 33.80 Microneedles Devices Market for Dissolving Microneedles, till 2035 (USD Million)
Table 33.81 Microneedles Devices Market for Coated Microneedles, till 2035 (USD Million)
Table 33.82 Microneedles Devices Market: Distribution by Type of Material Used
Table 33.83 Microneedles Devices Market for Polymer Microneedles, till 2035 (USD Million)
Table 33.84 Microneedles Devices Market for Silicon Microneedles, till 2035 (USD Million)
Table 33.85 Microneedles Devices Market for Metal Microneedles, till 2035 (USD Million)
Table 33.86 Microneedles Devices Market for Ceramic Microneedles, till 2035 (USD Million)
Table 33.87 Microneedle Devices Market: Distribution by Application Area
Table 33.88 Microneedle Devices Market for Insulin Delivery, till 2035 (USD Million)
Table 33.89 Microneedle Devices Market for Vaccination, till 2035 (USD Million)
Table 33.90 Microneedle Devices Market for Pain Management, till 2035 (USD Million)
Table 33.91 Microneedle Devices Market for Oncology, till 2035 (USD Million)
Table 33.92 Microneedle Devices Market: Distribution by Type of Intervention
Table 33.93 Microneedle Devices Market for Vaccines, till 2035 (USD Million)
Table 33.94 Microneedle Devices Market for Therapeutic Agents, till 2035 (USD Million)
Table 33.95 Microneedle Devices Market for Other Interventions, till 2035 (USD Million)
Table 33.96 Microneedle Devices Market: Distribution by Geography
Table 33.97 Microneedle Devices Market in North America, till 2035 (USD Million)
Table 33.98 Microneedle Devices Market in the US, till 2035 (USD Million)
Table 33.99 Microneedle Devices Market in Canada, till 2035 (USD Million)
Table 33.100 Microneedle Devices Market in Europe, till 2035 (USD Million)
Table 33.101 Microneedle Devices Market in Germany, till 2035 (USD Million)
Table 33.102 Microneedle Devices Market in the UK, till 2035 (USD Million)
Table 33.103 Microneedle Devices Market in France, till 2035 (USD Million)
Table 33.104 Microneedle Devices Market in Italy, till 2035 (USD Million)
Table 33.105 Microneedle Devices Market in Spain, till 2035 (USD Million)
Table 33.106 Microneedle Devices Market in Asia-Pacific, till 2035 (USD Million)
Table 33.107 Microneedle Devices Market in China, till 2035 (USD Million)
Table 33.108 Microneedle Devices Market in India, till 2035 (USD Million)
Table 33.109 Microneedle Devices Market in Japan, till 2035 (USD Million)
Table 33.110 Microneedle Devices Market in Australia, till 2035 (USD Million)
Table 33.111 Microneedle Devices Market in Middle East and North Africa, till 2035 (USD Million)
Table 33.112 Microneedle Devices Market in Egypt, till 2035 (USD Million)
Table 33.113 Microneedle Devices Market in Saudi Arabia, till 2035 (USD Million)
Table 33.114 Microneedle Devices Market in Israel, till 2035 (USD Million)
Table 33.115 Microneedle Devices Market in Latin America, till 2035 (USD Million)
Table 33.116 Microneedle Devices Market in Brazil, till 2035 (USD Million)
Table 33.117 Microneedle Devices Market in Argentina, till 2035 (USD Million)
Table 33.118 Microneedle Devices Market in Mexico, till 2035 (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

3M
Debiotech
INCYTO
Micropoint Technologies
NanoPass Technologies
Nemaura Pharma
Theraject
Antares Pharma
D’Antonio Consultants International
HNS International
Injex
INOVIO Pharmaceuticals
Medical International Technology
Mika Medical
Pharmajet
QS Medical Technology (Quinovare)
Zogenix

Methodology

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a single user license, allowing one user access to the product.	€4757EUR$4,799USD£3,949GBP
SITE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6938EUR$6,999USD£5,759GBP
ENTERPRISE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is an enterprise license, allowing all employees within your organization access to the product.	€17842EUR$17,999USD£14,809GBP

Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route of Administration, Actuation Mechanism, Product Usability, Application Area, Type of Load, Microneedle, Material Used, Intervention and Geography

Research Coverage:

Key Benefits of Buying this Report

Table of Contents

Companies Mentioned (Partial List)

Methodology

Research Coverage:

Key Benefits of Buying this Report

Table of Contents

Companies Mentioned (Partial List)

Methodology

Related Topics

Related Reports

Microneedle Flu Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Microneedle Drug Delivery Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Microneedles for Drug Delivery Patent Landscape Report and Forecast 2024-2032

Needle Free Drug Delivery Device Market by Technology, Application - Global Forecast 2025-2030

Microneedle Flu Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

About the Needle Free Drug Delivery Market